56 results
8-K
EX-4.1
UBX
Unity Biotechnology Inc
13 Nov 23
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
7:00am
or proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation
8-K
EX-99.2
cvy2pzci2
24 Apr 23
UNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:05am
8-K
EX-99.2
tb0d3oypo183fb3
1 Nov 22
UNITY Biotechnology Announces Positive 24-Week Data from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:00am
8-K
EX-4.1
px47khmk4j lo07q7
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
EX-1.1
p5d29wbpu5shxrkdu7
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
EX-99.2
89dfs0v1h9rxz uczv3a
12 Aug 22
UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:18am